association of cytopenia with survival in patients with b-cell lymphoma treated with car-t therapy
Published 1 year ago • 89 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:17
integrating car-t in community-based practices across b-cell lymphomas: key challenges
-
4:16
the challenges with car t-cell therapy for t-all and the progress made to overcome these challenges
-
3:21
practical considerations for car-t therapy in lymphoma
-
2:10
managing hematologic toxicity associated with car-t therapy & insights into the car-hematotox score
-
4:41
association of host hematopoiesis with car-t hematotoxicity and efficacy in lbcl
-
3:05
car-t therapy in r/r dlbcl
-
3:03
the impact of salvage and bridging therapy on car t-cell therapy outcomes in b-all: an itt analysis
-
1:38
challenges of car-t therapy in the real-world setting
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
3:43
car t-cell toxicity: crs, icans and prolonged cytopenias
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
2:23
prognostic value of alc following bcma car t-cell therapy in multiple myeloma
-
1:56
identifying and managing patients at high risk of developing toxicities following car-t therapy
-
3:07
the role of bridging and timing in car-t
-
1:42
challenges associated with car-t cell production
-
0:50
the practical challenges of using novel car t-cell agents
-
1:16
the efficacy of car t-cell therapy in richter’s transformation
-
10:22
cd19 car-t in lymphoma patients in the uk